Litigation Details for Takeda Pharmaceuticals U.S.A. v. Hikma Americas Inc. (Fed. Cir. 2014)

Takeda Pharmaceuticals U.S.A. v. Hikma Americas Inc. (Fed. Cir. 2014)

Docket		Date Filed	2014-11-07
Court	Court of Appeals for the Federal Circuit	Date Terminated
Cause		Assigned To
Jury Demand		Referred To
Patents	6,037,157; 7,601,758; 7,619,004; 7,820,681; 7,906,519; 7,915,269; 7,935,731; 7,964,647; 7,964,648; 7,981,938; 8,093,296; 8,093,297; 8,097,655; 8,440,722
Link to Docket	External link to docket

Details for Takeda Pharmaceuticals U.S.A. v. Hikma Americas Inc. (Fed. Cir. 2014)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2014-11-23	32		A 1/2000 TeagaJCden et al. 6,037,157 A 3/2000 Norbeck et al. …5,968,972 A 10/1999 Broder et al. 6,037.157 A 3/2000 Norbeck ct al. …. Such methods reduce the dangers com- 6,037,157 A 3/2000 Norbeck et al. …;655 patent), ketoconazole ('648 patent), or verapamil ('722 patent). The '938 patent is directed…655 patent), ketoconazole ('648 patent) , or verapamil ('722 patent). The '938 patent is directed	External link to document